{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T13:52:45Z","timestamp":1774360365007,"version":"3.50.1"},"reference-count":104,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Renal Nutrition"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1053\/j.jrn.2013.09.001","type":"journal-article","created":{"date-parts":[[2013,11,9]],"date-time":"2013-11-09T12:46:13Z","timestamp":1384001173000},"page":"143-150","source":"Crossref","is-referenced-by-count":15,"title":["Dietary and Pharmacological Modification of Fibroblast Growth Factor-23 in Chronic Kidney Disease"],"prefix":"10.1053","volume":"24","author":[{"given":"Aaltje Y.","family":"Adema","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin H.","family":"de Borst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piet M.","family":"ter Wee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc G.","family":"Vervloet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.jrn.2013.09.001_bib1","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.jrn.2013.09.001_bib2","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1523-1755.2003.00803.x","article-title":"Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients","volume":"63","author":"Kalantar-Zadeh","year":"2003","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2013.09.001_bib3","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5001514","article-title":"Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients","volume":"70","author":"Kalantar-Zadeh","year":"2006","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2013.09.001_bib4","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2013.09.001_bib5","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/jama.2011.308","article-title":"Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis","volume":"305","author":"Palmer","year":"2011","journal-title":"JAMA"},{"key":"10.1053\/j.jrn.2013.09.001_bib6","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/archinte.167.9.879","article-title":"Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community","volume":"167","author":"Dhingra","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.jrn.2013.09.001_bib7","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","article-title":"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia","volume":"98","author":"Shimada","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.jrn.2013.09.001_bib8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of FGF23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism","volume":"113","author":"Shimada","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1053\/j.jrn.2013.09.001_bib9","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease","volume":"16","author":"Gutierrez","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2013.09.001_bib10","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/sj.ki.5002451","article-title":"Vitamin D levels and early mortality among incident hemodialysis patients","volume":"72","author":"Wolf","year":"2007","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2013.09.001_bib11","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1053\/j.jrn.2013.09.001_bib12","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1046\/j.1523-1755.2003.00328.x","article-title":"Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers","volume":"64","author":"Larsson","year":"2003","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2013.09.001_bib13","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/ki.2012.176","article-title":"Update on fibroblast growth factor 23 in chronic kidney disease","volume":"82","author":"Wolf","year":"2012","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2013.09.001_bib14","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1001\/jama.2012.3954","article-title":"Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate","volume":"307","author":"Matsushita","year":"2012","journal-title":"JAMA"},{"key":"10.1053\/j.jrn.2013.09.001_bib15","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/j.ajkd.2004.04.029","article-title":"Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency","volume":"44","author":"Shigematsu","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2013.09.001_bib16","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1523-1755.2005.00184.x","article-title":"Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients","volume":"67","author":"Nakanishi","year":"2005","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2013.09.001_bib17","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"10.1053\/j.jrn.2013.09.001_bib18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2215\/CJN.04250510","article-title":"FGF-23 as a predictor of renal outcome in diabetic nephropathy","volume":"6","author":"Titan","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2013.09.001_bib19","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1681\/ASN.2006080936","article-title":"Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) study","volume":"18","author":"Fliser","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2013.09.001_bib20","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1053\/j.jrn.2013.09.001_bib21","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.semnephrol.2012.12.018","article-title":"Management of natural and added dietary phosphorus burden in kidney disease","volume":"33","author":"Cupisti","year":"2013","journal-title":"Semin Nephrol"},{"key":"10.1053\/j.jrn.2013.09.001_bib22","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/MNH.0b013e32836214d4","article-title":"Use of phosphate binders in chronic kidney disease","volume":"22","author":"Ketteler","year":"2013","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1053\/j.jrn.2013.09.001_bib23","doi-asserted-by":"crossref","first-page":"597605","DOI":"10.1155\/2012\/597605","article-title":"Phosphorus and nutrition in chronic kidney disease","volume":"2012","author":"Gonzalez-Parra","year":"2012","journal-title":"Int J Nephrol"},{"key":"10.1053\/j.jrn.2013.09.001_bib24","first-page":"592","article-title":"Not all phosphate is created equal","volume":"22","author":"Ketteler","year":"2012","journal-title":"J\u00a0Ren Nutr"},{"key":"10.1053\/j.jrn.2013.09.001_bib25","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1053\/j.ajkd.2013.03.042","article-title":"Phosphate homeostasis in CKD: report of a scientific symposium sponsored by the National Kidney Foundation","volume":"62","author":"Block","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2013.09.001_bib26","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2215\/CJN.06080809","article-title":"Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease","volume":"5","author":"Kalantar-Zadeh","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"suppl 1","key":"10.1053\/j.jrn.2013.09.001_bib27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1755-6686.2009.00064.x","article-title":"Early initiation of phosphate lowering dietary therapy in non-dialysis chronic kidney disease: a critical review","volume":"35","author":"Sigrist","year":"2009","journal-title":"J Ren Care"},{"key":"10.1053\/j.jrn.2013.09.001_bib28","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1056\/NEJMra0912522","article-title":"Oral phosphate binders in patients with kidney failure","volume":"362","author":"Tonelli","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2013.09.001_bib29","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.2215\/CJN.13021212","article-title":"Single FGF-23 measurement and time-averaged plasma phosphate levels in hemodialysis patients","volume":"8","author":"Seiler","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2013.09.001_bib30","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ki.2008.130","article-title":"Hyperphosphatemia of chronic kidney disease","volume":"74","author":"Hruska","year":"2008","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2013.09.001_bib31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/ndt\/gfs405","article-title":"Responsiveness of FGF-23 and mineral metabolism to altered dietary phosphate intake in chronic kidney disease (CKD): results of a randomized trial","volume":"28","author":"Sigrist","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2013.09.001_bib32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2215\/CJN.04730510","article-title":"Effects of dietary phosphate and calcium intake on fibroblast growth factor-23","volume":"6","author":"Vervloet","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2013.09.001_bib33","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000098544","article-title":"Phosphate salivary secretion in hemodialysis patients: implications for the treatment of hyperphosphatemia","volume":"105","author":"Savica","year":"2007","journal-title":"Nephron Physiol"},{"key":"10.1053\/j.jrn.2013.09.001_bib34","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1053\/j.jrn.2007.10.018","article-title":"Salivary phosphate secretion in chronic kidney disease","volume":"18","author":"Savica","year":"2008","journal-title":"J Ren Nutr"},{"key":"10.1053\/j.jrn.2013.09.001_bib35","doi-asserted-by":"crossref","first-page":"F285","DOI":"10.1152\/ajprenal.00508.2009","article-title":"Phosphate homeostasis and the renal-gastrointestinal axis","volume":"299","author":"Marks","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1053\/j.jrn.2013.09.001_bib36","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/ki.2011.118","article-title":"Nutrition and chronic kidney disease","volume":"80","author":"Fouque","year":"2011","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2013.09.001_bib37","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0002-8223(96)00331-8","article-title":"Regression equation predicts dietary phosphorus intake from estimate of dietary protein intake","volume":"96","author":"Boaz","year":"1996","journal-title":"J Am Diet Assoc"},{"key":"10.1053\/j.jrn.2013.09.001_bib38","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2215\/CJN.07640711","article-title":"Acute effects of very-low-protein diet\u00a0on FGF23 levels: a randomized study","volume":"7","author":"Di","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2013.09.001_bib39","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1681\/ASN.V10112426","article-title":"Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group","volume":"10","author":"Levey","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2013.09.001_bib40","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.3945\/ajcn.2008.26665","article-title":"Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?","volume":"88","author":"Shinaberger","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/j.jrn.2013.09.001_bib41","doi-asserted-by":"crossref","first-page":"620","DOI":"10.2215\/CJN.04620510","article-title":"Prescribed dietary phosphate restriction and survival among hemodialysis patients","volume":"6","author":"Lynch","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2013.09.001_bib42","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1053\/j.jrn.2011.12.010","article-title":"Novel differential measurement of natural and added phosphorus in cooked ham with or without preservatives","volume":"22","author":"Cupisti","year":"2012","journal-title":"J Ren Nutr"},{"key":"10.1053\/j.jrn.2013.09.001_bib43","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/jama.2009.96","article-title":"Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial","volume":"301","author":"Sullivan","year":"2009","journal-title":"JAMA"},{"issue":"suppl 2","key":"10.1053\/j.jrn.2013.09.001_bib44","doi-asserted-by":"crossref","first-page":"S330","DOI":"10.1002\/mnfr.200900099","article-title":"Phytate in foods and significance for humans: food sources, intake, processing, bioavailability, protective role and analysis","volume":"53","author":"Schlemmer","year":"2009","journal-title":"Mol Nutr Food Res"},{"key":"10.1053\/j.jrn.2013.09.001_bib45","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ki.2008.456","article-title":"A rat model of chronic kidney disease-mineral bone disorder","volume":"75","author":"Moe","year":"2009","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2013.09.001_bib46","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2215\/CJN.05040610","article-title":"Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease","volume":"6","author":"Moe","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2013.09.001_bib47","first-page":"379","article-title":"Plant protein intake is associated with fibroblast growth factor 23 and serum bicarbonate levels in patients with chronic kidney disease: the Chronic Renal Insufficiency Cohort study","volume":"22","author":"Scialla","year":"2012","journal-title":"J\u00a0Ren Nutr"},{"key":"10.1053\/j.jrn.2013.09.001_bib48","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0272-6386(03)00905-3","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2013.09.001_bib49","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S0002-8223(21)07957-8","article-title":"Accuracy of methods estimating calcium and phosphorus intake in daily diets","volume":"88","author":"Oenning","year":"1988","journal-title":"J Am Diet Assoc"},{"key":"10.1053\/j.jrn.2013.09.001_bib50","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1053\/j.jrn.2010.05.014","article-title":"Dietary phosphate assessment in dialysis patients","volume":"20","author":"Mathewson","year":"2010","journal-title":"J Ren Nutr"},{"key":"10.1053\/j.jrn.2013.09.001_bib51","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1681\/ASN.2008020130","article-title":"Salivary phosphate-binding chewing gum reduces hyperphosphatemia in dialysis patients","volume":"20","author":"Savica","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2013.09.001_bib52","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1681\/ASN.2008060609","article-title":"Phosphorus binders and survival on hemodialysis","volume":"20","author":"Isakova","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2013.09.001_bib53","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1053\/j.ajkd.2010.06.011","article-title":"Outcomes associated with phosphorus binders in men with non-dialysis-dependent CKD","volume":"56","author":"Kovesdy","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2013.09.001_bib54","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1053\/j.ajkd.2009.06.004","article-title":"Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials","volume":"54","author":"Navaneethan","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2013.09.001_bib55","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2013.09.001_bib56","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/ndt\/15.7.1014","article-title":"Arterial stiffening and vascular calcifications in end-stage renal disease","volume":"15","author":"Guerin","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2013.09.001_bib57","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","article-title":"Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality","volume":"18","author":"London","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2013.09.001_bib58","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","article-title":"Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"52","author":"Tentori","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2013.09.001_bib59","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0272-6386(04)01103-5","article-title":"Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"44","author":"Young","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2013.09.001_bib60","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2013.09.001_bib61","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1093\/ndt\/gfm539","article-title":"Serum phosphorus and the risk of progression of chronic kidney disease","volume":"22","author":"Kovesdy","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2013.09.001_bib62","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","article-title":"Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients","volume":"12","author":"Ganesh","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2013.09.001_bib63","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","article-title":"Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients","volume":"62","author":"Chertow","year":"2002","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2013.09.001_bib64","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000072822","article-title":"The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patients","volume":"23","author":"Chertow","year":"2003","journal-title":"Am J Nephrol"},{"key":"10.1053\/j.jrn.2013.09.001_bib65","doi-asserted-by":"crossref","first-page":"104","DOI":"10.5414\/CNP62104","article-title":"Long-term comparison of a calcium-free phosphate binder and calcium carbonate\u2013phosphorus metabolism and cardiovascular calcification","volume":"62","author":"Braun","year":"2004","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.jrn.2013.09.001_bib66","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1093\/ndt\/gfh894","article-title":"Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density","volume":"20","author":"Asmus","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2013.09.001_bib67","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1053\/j.ajkd.2008.02.298","article-title":"A 1-year randomized trial of\u00a0calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study","volume":"51","author":"Qunibi","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2013.09.001_bib68","doi-asserted-by":"crossref","first-page":"c273","DOI":"10.1159\/000170783","article-title":"Phosphate binder impact on bone remodeling and coronary calcification\u2013results from the BRiC study","volume":"110","author":"Barreto","year":"2008","journal-title":"Nephron Clin Pract"},{"key":"10.1053\/j.jrn.2013.09.001_bib69","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1681\/ASN.2012030223","article-title":"Effects of phosphate binders in moderate CKD","volume":"23","author":"Block","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2013.09.001_bib70","doi-asserted-by":"crossref","first-page":"c259","DOI":"10.1159\/000313484","article-title":"Meta-analysis comparing sevelamer and calcium-based phosphate binders on cardiovascular calcification in hemodialysis patients","volume":"115","author":"Zhang","year":"2010","journal-title":"Nephron Clin Pract"},{"key":"10.1053\/j.jrn.2013.09.001_bib71","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2215\/CJN.05060610","article-title":"Comparative effectiveness of calcium-containing phosphate binders in incident U.S. dialysis patients","volume":"6","author":"Winkelmayer","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2013.09.001_bib72","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1093\/ndt\/gfm421","article-title":"Systematic review of the clinical efficacy and safety of sevelamer in dialysis patients","volume":"22","author":"Tonelli","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2013.09.001_bib73","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1093\/ndt\/gfp350","article-title":"The effects of calcium-based versus non-calcium-based phosphate binders on mortality among patients with chronic kidney disease: a meta-analysis","volume":"24","author":"Jamal","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2013.09.001_bib74","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/sj.ki.5002466","article-title":"Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients","volume":"72","author":"Suki","year":"2007","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2013.09.001_bib75","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/sj.ki.5002059","article-title":"Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients","volume":"71","author":"Block","year":"2007","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2013.09.001_bib76","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2215\/CJN.03820411","article-title":"Mortality in kidney disease patients treated with phosphate binders: a randomized study","volume":"7","author":"Di","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2013.09.001_bib77","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2215\/CJN.05420709","article-title":"Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?","volume":"5","author":"Oliveira","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2013.09.001_bib78","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/ndt\/gfq419","article-title":"Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease","volume":"26","author":"Isakova","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2013.09.001_bib79","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1093\/ndt\/gfr144","article-title":"Lanthanum carbonate reduces FGF23 in chronic kidney disease Stage 3 patients","volume":"26","author":"Gonzalez-Parra","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2013.09.001_bib80","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2215\/CJN.09250912","article-title":"Effects of dietary phosphate restriction and phosphate binders on FGF23 levels in CKD","volume":"8","author":"Isakova","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2013.09.001_bib81","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1053\/j.ajkd.2011.11.007","article-title":"Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: a randomized clinical trial","volume":"59","author":"Yilmaz","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2013.09.001_bib82","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1471-2369-13-49","article-title":"Fibroblast growth factor 23 and parathyroid hormone after treatment with\u00a0active vitamin D and sevelamer carbonate in patients with chronic kidney disease stage 3b, a randomized crossover trial","volume":"13","author":"Bleskestad","year":"2012","journal-title":"BMC Nephrol"},{"key":"10.1053\/j.jrn.2013.09.001_bib83","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000351811","article-title":"Effect of a non-calcium-based phosphate binder on fibroblast growth factor 23 in chronic kidney disease","volume":"123","author":"Spatz","year":"2013","journal-title":"Nephron Clin Pract"},{"key":"10.1053\/j.jrn.2013.09.001_bib84","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1744-9987.2005.00293.x","article-title":"Sevelamer hydrochloride and calcium bicarbonate reduce serum fibroblast growth factor 23 levels in dialysis patients","volume":"9","author":"Koiwa","year":"2005","journal-title":"Ther Apher Dial"},{"key":"10.1053\/j.jrn.2013.09.001_bib85","doi-asserted-by":"crossref","first-page":"c74","DOI":"10.1159\/000319650","article-title":"Fibroblast growth factor 23 in hemodialysis patients: effects of phosphate binder, calcitriol and calcium concentration in the dialysate","volume":"117","author":"Cancela","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"10.1053\/j.jrn.2013.09.001_bib86","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/ki.2011.350","article-title":"PTH, FGF23, and calcium: it takes three to tango?","volume":"80","author":"Evenepoel","year":"2011","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2013.09.001_bib87","doi-asserted-by":"crossref","first-page":"F1088","DOI":"10.1152\/ajprenal.00474.2004","article-title":"Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism","volume":"289","author":"Shimada","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1053\/j.jrn.2013.09.001_bib88","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1681\/ASN.2011101006","article-title":"Calcium deficiency reduces circulating levels of FGF23","volume":"23","author":"Rodriguez-Ortiz","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2013.09.001_bib89","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1681\/ASN.V1161141","article-title":"Cell biology of parathyroid gland hyperplasia in chronic renal failure","volume":"11","author":"Drueke","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2013.09.001_bib90","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/ki.2009.466","article-title":"FGF23-parathyroid interaction: implications in chronic kidney disease","volume":"77","author":"Komaba","year":"2010","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2013.09.001_bib91","first-page":"4003","article-title":"The parathyroid is a target organ for FGF23 in rats","volume":"117","author":"Ben-Dov","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1053\/j.jrn.2013.09.001_bib92","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/j.1523-1755.2005.00178.x","article-title":"Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients","volume":"67","author":"Kazama","year":"2005","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2013.09.001_bib93","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/ki.2010.260","article-title":"Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients","volume":"78","author":"Krajisnik","year":"2010","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2013.09.001_bib94","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/ki.2011.445","article-title":"Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation","volume":"81","author":"Sun","year":"2012","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2013.09.001_bib95","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/ki.2009.414","article-title":"Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients","volume":"77","author":"Komaba","year":"2010","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2013.09.001_bib96","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.ajkd.2004.05.026","article-title":"Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism","volume":"44","author":"Sato","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2013.09.001_bib97","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis","volume":"350","author":"Block","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2013.09.001_bib98","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/ndt\/gfm534","article-title":"Cinacalcet (KRN1493) effectively decreases the serum intact PTH level with favorable control of the serum phosphorus and calcium levels in Japanese dialysis patients","volume":"23","author":"Fukagawa","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2013.09.001_bib99","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.2215\/CJN.01040308","article-title":"Cinacalcet HCl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: the ACHIEVE study results","volume":"3","author":"Fishbane","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2013.09.001_bib100","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.2215\/CJN.02110310","article-title":"Cinacalcet effectively reduces parathyroid hormone secretion and gland volume regardless of pretreatment gland size in patients with secondary hyperparathyroidism","volume":"5","author":"Komaba","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2013.09.001_bib101","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2215\/CJN.03630509","article-title":"Effects of cinacalcet and concurrent low-dose vitamin D on FGF23 levels in ESRD","volume":"5","author":"Wetmore","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2013.09.001_bib102","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s11255-011-0050-7","article-title":"Cinacalcet lowers FGF-23 level together with bone metabolism in hemodialyzed patients with secondary hyperparathyroidism","volume":"44","author":"Hryszko","year":"2012","journal-title":"Int Urol Nephrol"},{"key":"10.1053\/j.jrn.2013.09.001_bib103","doi-asserted-by":"crossref","first-page":"E1101","DOI":"10.1152\/ajpendo.00502.2004","article-title":"Vitamin D and phosphate regulate fibroblast growth factor-23 in K-562 cells","volume":"288","author":"Ito","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1053\/j.jrn.2013.09.001_bib104","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1681\/ASN.2005111185","article-title":"Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D","volume":"17","author":"Liu","year":"2006","journal-title":"J Am Soc Nephrol"}],"container-title":["Journal of Renal Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051227613001635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051227613001635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T23:36:58Z","timestamp":1647041818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051227613001635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":104,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S1051227613001635"],"URL":"https:\/\/doi.org\/10.1053\/j.jrn.2013.09.001","relation":{},"ISSN":["1051-2276"],"issn-type":[{"value":"1051-2276","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}